The Positioning of IBD Treatments for Your Patients
New Treatment Update
David Choi, MD
Therapeutic Drug Monitoring and Treat to Target
Byron Vaughn, MD, MS
The Evolution of Treating Ulcerative Colitis
Edward V. Loftus, JR., M.D.
Management of Fulminant Ulcerative Colitis
Parambir S. Dulai, MD
Updates in IBD Dysplasia Screening
Jesse Lee Stondell, M.D.
Post-Operative Crohns Disease
Maneesh Dave, M.D., M.P.H.
Microbiome in IBD
Ronald Hsu, M.D., FACG, FACP
Checkpoint Inhibitor Colitis
Michael Kattah, MD, PhD
Emerging Therapies in Inflammatory Bowel Disease
Peter D. Higgins, MD, PhD
Through the Looking Glass: Managing IBD Care for Diverse Patient Populations
Lisa B. Malter, MD
A Multi-Disciplinary Panel Discussion
Freddy Caldera, DO
Shubha Bhat, PharmD, MS, BCACP
Stacy A Ogbeide, PSYD, ABPP, CSOWM
Positioning Therapies in Inflammatory Bowel Disease
Eric J. Mao, M.D.
Basics of Medical Management of IBD
Treat-To-Target and Therapy De-Escalation
Christina Ha, MD, FACG, AGAF
Fellow Foundations Lecture 2: Incorporating Biosimilars into Clinical Practice
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.